Theriva Biologics, Inc. (TOVX)

0.2455 -0.01 (-2.96%) USD  |  NYAM  |  Sep 08, 10:39
More

Theriva Biologics Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Research and Development Expense (% of Annual Revenues) Data

View and export this data back to 2009. Start Trial.
Date Value
December 31, 2010 --
Date Value
December 31, 2009 --

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. Upgrade
Yarrow Bioscience, Inc. Upgrade
Nkarta, Inc. --
Unicycive Therapeutics, Inc. --
OnKure Therapeutics, Inc. --